Novel DMARD monotherapy in rheumatoid arthritis

Affiliations

¹ Rheumatology Department, Cochin Hospital, 75014 Paris, France.
² Rheumatology Department, Cochin Hospital, 75014 Paris, France. Electronic address: maxime.dougados@aphp.fr.

Comment

Anna Moltó et al. Lancet. 2019.

. 2019 Jun 8;393(10188):2277-2278.

doi: 10.1016/S0140-6736(19)30768-8. Epub 2019 Jun 6.

¹ Rheumatology Department, Cochin Hospital, 75014 Paris, France.
² Rheumatology Department, Cochin Hospital, 75014 Paris, France. Electronic address: maxime.dougados@aphp.fr.

No abstract available

Comment on

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study.
Smolen JS, Pangan AL, Emery P, Rigby W, Tanaka Y, Vargas JI, Zhang Y, Damjanov N, Friedman A, Othman AA, Camp HS, Cohen S. Smolen JS, et al. Lancet. 2019 Jun 8;393(10188):2303-2311. doi: 10.1016/S0140-6736(19)30419-2. Epub 2019 May 23. Lancet. 2019. PMID: 31130260 Clinical Trial.